Genomma Lab Internacional, a leading player in the pharmaceutical and personal care industry, is headquartered in Mexico (MX) and operates extensively across Latin America and the United States. Founded in 2000, the company has achieved significant milestones, including rapid expansion and a diverse product portfolio that encompasses over-the-counter medications, skincare, and dietary supplements. Renowned for its innovative approach, Genomma Lab offers unique formulations that cater to various health and wellness needs, setting it apart in a competitive market. With a strong commitment to quality and research, the company has established a solid market position, recognised for its effective solutions and consumer trust. Genomma Lab Internacional continues to thrive, driven by its dedication to enhancing the well-being of its customers.
How does Genomma Lab Internacional's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Genomma Lab Internacional's score of 34 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Genomma Lab Internacional reported total carbon emissions of approximately 51,000,000 kg CO2e, comprising 3,100,840 kg CO2e from Scope 1, 4,740,490 kg CO2e from Scope 2, and 44,075,120 kg CO2e from Scope 3 emissions. This represents a slight increase in emissions compared to 2022, where total emissions were about 43,466,980 kg CO2e for Scope 3, 4,041,110 kg CO2e for Scope 2, and 2,737,470 kg CO2e for Scope 1. The company has not set specific reduction targets or initiatives as part of the Science Based Targets initiative (SBTi) or other climate pledges. However, it continues to disclose its emissions data transparently, which is crucial for tracking progress in sustainability efforts. Genomma Lab's emissions data is not cascaded from any parent organization, indicating that the figures are independently reported. The company operates with a focus on reducing its carbon footprint, particularly in its industrial complex in Mexico, where it has reported an emission intensity of approximately 650 kg CO2e per tonne produced. Overall, while Genomma Lab Internacional has not established formal reduction targets, its commitment to transparency in emissions reporting is a step towards addressing climate change impacts.
Access structured emissions data, company-specific emission factors, and source documents
2014 | 2015 | 2016 | 2017 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|
Scope 1 | 198,500 | 000,000 | 00,000 | 000,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 570,700 | 000,000 | 000,000 | 0,000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genomma Lab Internacional is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.